Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q1 FY23 results · Apr–Jun 2022
Max Healthcare Institute reported revenue from operations of ₹1,066.27 crore (up 6.6% from Q1 FY22) and net profit of ₹172.83 crore (up 17.6% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,066.27 | 1,000.17 | +6.6% | 938.80 | +13.6% |
| Other income | 31.51 | 25.96 | +21.4% | 24.71 | +27.5% |
| Total income | 1,097.78 | 1,026.13 | +7.0% | 963.51 | +13.9% |
| Profit before tax | 216.38 | 189.85 | +14.0% | 154.39 | +40.2% |
| Net profit for the period | 172.83 | 146.92 | +17.6% | 123.73 | +39.7% |
| EPS, basic (₹) | 1.78 | 1.52 | +17.1% | 1.28 | +39.1% |
| Net margin (%) | 16.2 | 14.7 | 13.2 |
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 426.55 | 500.21 | −14.7% | 381.20 | +11.9% |
| Other income | 28.77 | 27.16 | +5.9% | 27.91 | +3.1% |
| Total income | 455.32 | 527.37 | −13.7% | 409.11 | +11.3% |
| Profit before tax | 109.94 | 114.98 | −4.4% | 82.54 | +33.2% |
| Net profit for the period | 85.26 | 87.92 | −3.0% | 66.15 | +28.9% |
| EPS, basic (₹) | 0.88 | 0.91 | −3.3% | 0.68 | +29.4% |
| Net margin (%) | 20.0 | 17.6 | 17.4 |
Consolidated
- Filed with BSE
- 11 Aug 2022, 12:03 IST
- Board meeting
- 10 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Aug 2022, 12:03 IST
- Board meeting
- 10 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE